K Number
K982368
Device Name
MANIFOLD WITH EXTENSION SET
Date Cleared
1998-07-31

(24 days)

Product Code
Regulation Number
880.5440
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Interpore Cross International Manifold with Extension Set is intended to provide multiple access sites into a common fluid path for blood, plasma or solutions. The luer connectors on either end of the stopcock gang allow connection to the Extension Set for fluid transfer (i.e., blood, plasma, or solution).
Device Description
The Interpore Cross Manifold with Extension Set consists of individual stopcocks assembled in series through common luer fittings to form a manifold or stopcock gang. These pre-assembled stopcock gangs provide multiple access sites into a common fluid path for blood, plasma or solutions. The luer connectors on either end of the stopcock gang (Manifold) allow connection to the Extension Set for fluid transfer. The backing plate can be used to attach the stopcock manifold gang to an IV pole.
More Information

Not Found

No
The device description and performance studies focus on the mechanical and fluid handling properties of a stopcock manifold, with no mention of AI or ML.

No
The device is described as providing multiple access sites for fluid transfer (blood, plasma, or solutions) and is designed for mechanical function and fluid handling, not for direct therapeutic intervention on the patient.

No

This device is described as providing multiple access sites for fluid transfer, such as blood, plasma, or solutions, and its performance studies focus on functional aspects like leakage and flow rate. There is no mention of it being used to gather information about a patient's health status or to diagnose a condition.

No

The device description clearly outlines physical components like stopcocks, luer fittings, and a backing plate, indicating it is a hardware device for fluid transfer.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to provide multiple access sites for fluid transfer (blood, plasma, solutions) within a common fluid path. This is a function related to the administration or handling of fluids within the body or for therapeutic purposes, not for the examination of specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes.
  • Device Description: The description details a system of stopcocks and extension sets for fluid management, not for analyzing biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing specimens, detecting analytes, or providing diagnostic information.

IVD devices are specifically designed to perform tests on samples like blood, urine, tissue, etc., to diagnose diseases, monitor conditions, or determine compatibility. This device's function is purely related to fluid handling and administration.

N/A

Intended Use / Indications for Use

The Interpore Cross International Manifold with Extension Set is intended to provide multiple access sites into a common fluid path for blood, plasma or solutions. The luer connectors on either end of the stopcock gang allow connection to an Extension Set for fluid transfer (i.e., blood, plasma, or solution).

Product codes

FMG

Device Description

The Interpore Cross Manifold with Extension Set consists of individual stopcocks assembled in series through common luer fittings to form a manifold or stopcock gang. These pre-assembled stopcock gangs provide multiple access sites into a common fluid path for blood, plasma or solutions. The luer connectors on either end of the stopcock gang (Manifold) allow connection to the Extension Set for fluid transfer. The backing plate can be used to attach the stopcock manifold gang to an IV pole.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Data regarding the functional performance of the proposed Manifold have been generated. Testing included ease of assembly, unscrewing torque, air leakage, liquid leakage, separation force, resistance to overriding, pressure seal testing, Manifold flow rate, mechanical security of stopcock gangs to backing plate. The data indicate that the proposed Manifold meets or exceeds all functional requirements and support its suitability for use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K962531

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 880.5440 Intravascular administration set.

(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

0

JUL 3 | 1998

K982368

Interpore Cross Manifold With Extension Set

Interpore Cross International - Confidential -

510(K) SUMMARY

SUBMITTED BY

Lynn Rodarti Manager, Regulatory Affairs INTERPORE International 181 Technology Drive Irvine, California 92618

(714) 453-3200

Date Submitted: July 2, 1998

CLASSIFICATION, COMMON OR USUAL NAME, DEVICE NAME

Classification Name: Stopcock, I.V. Set Common/Usual Name: Stopcock Manifold Product Classification: Class II Proprietary Name: Manifold with Extension Set

PREDICATE DEVICE

Medex Guide-Flo Stopcock Manifold Gangs, Preamendment Device and Baxter Stopcock Manifold Gangs, 510(k) K962531.

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR §807.92.

INDICATIONS-FOR-USE

The Interpore Cross International Manifold with Extension Set is intended to provide multiple access sites into a common fluid path for blood, plasma or The luer connectors on either end of the stopcock gang allow solutions. connection to an Extension Set for fluid transfer (i.e., blood, plasma, or solution).

DEVICE DESCRIPTION

The Interpore Cross Manifold with Extension Set consists of individual stopcocks assembled in series through common luer fittings to form a manifold or stopcock gang. These pre-assembled stopcock gangs provide multiple access sites into a common fluid path for blood, plasma or solutions.

1

Interpore Cross Manifold With Extension Set

The luer connectors on either end of the stopcock gang (Manifold) allow connection to the Extension Set for fluid transfer. The backing plate can be used to attach the stopcock manifold gang to an IV pole.

COMPARISON TO THE PREDICATE DEVICE

Cross Manifold with Extension Set is technologically The Interpore substantially equivalent to the predicate devices in every respect.

DISCUSSION OF NONCLINICAL TESTS

Data regarding the functional performance of the proposed Manifold have been generated. Testing included ease of assembly, unscrewing torque, air leakage, liquid leakage, separation force, resistance to overriding, pressure seal testing, Manifold flow rate, mechanical security of stopcock gangs to backing plate. The data indicate that the proposed Manifold meets or exceeds all functional requirements and support its suitability for use.

2

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

. || "

JUL 31 1998

Ms. Lynn Rodarti Manager, Regulatory Affairs Interpore Cross International 181 Technology Drive Irvine, California 92618

K982368 Re : Manifold with Extension Set Trade Name: Regulatory Class: II Product Code: FMG Dated: July 6, 1998 Received: July 7, 1998

Dear Ms. Rodarti:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of

3

Page 2 - Ms. Rodarti

the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

S. Sutro fer

Timothy A. Ulatowski Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

K982368

Page 1 of 1

510(k) Number (if known):

Manifold with Extension Set Device Name:

Indications-For-Use:

The Interpore Cross International Manifold with Extension Set is intended to provide multiple access sites into a common fluid path for blood, plasma or solutions. The luer connectors on either end of the stopcock gang allow connection to the Extension Set for fluid transfer (i.e., blood, plasma, or solution).

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Patricia Cincenti

(Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number _

Prescription Use
(PER 21 CFR 801.109)

OR

Over-The-Counter Use

(Optional Format 1-2-96)